4 minute read
London Biotechnology Show 2024 review
The London Biotechnology Show is the leading UK biotechnology event for the industry, helping drive cutting-edge innovations across medical and healthcare sectors nationally and around the globe.
This year’s show was held from 8th-9th May at London’s Olympia, bringing key stakeholders together with over 72 leading national and international exhibitors for two action-packed days under one roof. With industry-leading keynote speaker, thought-provoking panel discussions, exclusive new product launches and promising sales leads, attendees and exhibitors alike were impressed by the event organisation and high-quality footfall.
The show primarily focused on the following areas: Pharmaceutical Biotechnology, Genomics and Genetic Engineering, Molecular Diagnostics & Advanced Therapeutics, Medical Devices and Biomedical Engineering, Regenerative Medicine and Tissue Engineering, Digital Health and Healthcare Informatics, Agri Tech and Food Tech, Environment & Sustainability, Nutraceuticals, and Biostimulants.
Exhibitors were able to showcase new products and services, generate high-quality new sales leads and sales pipelines, create brand awareness and gain industry awareness from global think tanks and individuals.
Noteworthy speakers included scientist George Prout discussing ‘Rapid Process Development for Bioreactor Scale-Up (using HEK 293 cells for AAV production)’ and Charles Hickson, Deputy Head –Strategic Sectors at UK Export Finance (UKEF) gave a fascinating session on UK Government Support for The Life Science Sector to a full audience.
Other hot topics included: biopharma, biomanufacturing, next generation synthetic DNA, bio innovations and the potential of R&D tax relief as a strong non-dilutive funding source.
One of the prized featured speakers: Dr Alexander Ariel Padron Gonzalez praised the show, “The sheer number of people you can connect with here to enhance your network and foster collaborations is astounding.” The networking possibilities were endless, allowing many companies to not only showcase products and services to a vested audience but also meet prospective regional partners.
The scale of innovation was truly breathtaking from enterprising start-ups to more established companies including: benchtop systems for dental prostheses, rotating spiral biofilm bioreactors and ethical (pre-clinical testing) with customised living organ systems.
Artificial Intelligence featured heavily at the two-day event, which was to be expected with predictions showing that adopted AI programmes could help eradicate healthcare medication dosing mistakes over the coming years and exciting developments evolving in neonatal care in particular. Panel discussions focused on Genomics, Proteomics, Bioinformatics, Clinical Trials through to Recombinant DNA Technologies.
The president and CEO of AltruBio Inc: Dr Judy H. Chou in particular, gave a memorable, thoughtprovoking presentation on ‘Restorative Medicine: restoring tissue function through stem cell therapies.
Over 4,000 visitors attended this year’s show and came from a diverse range of backgrounds including researchers, policymakers, investors and entrepreneurs, with many enthusing about the quality of exchanges and exhibitors, “Meetings like this one are the lifeblood of the biotech industry, at a time when connection, collaboration and investment are needed the most.”
The Startup Showcase gave an opportunity for newcomers to meet industrial experts, especially the Startup Pitching Programme which was a dynamic pitching experience for wannabee entrepreneurs to have a go at selling ideas in front of an audience packed with experts.
Here at Healthcare Matters, we have hand-picked out four Top Exhibitors from across the show:
Restore Harrow Green Laboratory Services: These expert, trustworthy movers can offer complete lab relocation programmes, including confidential data, chemicals, precious research samples, refrigerated components, instruments, and precision equipment.
Avidity Science: Innovative water purification and delivery systems. During this show, the team showcased a range of lab water purification systems for a diverse range of applications, including the new sustainable Solo™ S unit.
Hammersmith Medicines Research Ltd: This clinical research organisation focuses on early clinical trials of new medicines for pharmaceutical and biotechnology companies across the globe. It is the largest organisation of its type in the UK field, has completed over 1,000 trials and can provide study designs and clinical reports.
MTS Cryostores: Experts in bio banking & bio-repository, archive sample storage, disaster recovery and specialist sample transport. The HLT fully licensed company has engineers on call 24 hours a day, on every day of the year.
The UK Government has always traditionally supported the UK medical/biotechnology industry, recognising its leading position in the global arena. The market is set to grow further by 7.1% over the next few years due to sustained investments and cutting-edge technology advancements, cementing further R&D and global sphere of influence.
Biotechnology plays a pivotal role in medical healthcare through pioneering breakthroughs in R&D that revolutionises medical trials, leads to undiscovered knowledge and ultimately lifesaving cures.
Next year’s London Biotechnology Show will take place at London’s ExCeL, the first venue in the country to become carbon-neutral. It has been awarded the PAS 2060 certification by Carbon Saver: the only international recognised standard for carbon neutrality.
Save the date:London Biotechnology Show 202518th-19th JuneExCeL Londonhttps://londonbiotechshow.com
